Target Verticals
Investment Criteria
BlueStone invests in early-stage startups that operate within the Life Sciences. The Fund primarily focuses on companies that reside within our “Core Four” verticals which are: Medical Devices, Diagnostics, Digital Health, and Life Science Research Tools
We seek companies that have developed transformative platforms or disruptive technologies, are protected by strong intellectual property, and will have a meaningful impact on healthcare. Our preference is for companies residing in the NATO States (New Mexico, Arizona, Texas, and Oklahoma), however, as a return-driven fund, we will make investments in US based companies regardless of geography if they fit our “Southwest-like” metrics.
BlueStone provides growth capital and strategic support to our portfolio companies in addition to privileged access to strategic partners including investors, customers, and other partners residing within the supply chain.
| Target Company Characteristics Sought |
|---|
| 1. Business-to-Business commercial model |
| 2. Clear milestone based pathways: a) through the regulatory process, and b) to commercialization |
| 3. Strong, proven founder and leadership teams |
| 4. Efficient use of capital; <$50M invested capital required through Exit |
| 5. Well defined exit plan with multiple options |
| Other Information About BlueStone |
|---|
| Target Series A/B financing rounds – willing to look at Seed stage companies |
| Typical check sizes between $250K and $1M |
| Preference for companies in the NATO States |
| Willing to lead/co-lead rounds |
| Seek a Board Seat as part of our investment |